Found: 34
Select item for more details and to access through your institution.
Protection against cardiac hypertrophy by geniposide involves the GLP-1 receptor / AMPKα signalling pathway.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cucurbitacin B Protects Against Pressure Overload Induced Cardiac Hypertrophy.
- Published in:
- Journal of Cellular Biochemistry, 2017, v. 118, n. 11, p. 3899, doi. 10.1002/jcb.26041
- By:
- Publication type:
- Article
Baicalein protects against cardiac hypertrophy through blocking MEK-ERK1/2 signaling.
- Published in:
- Journal of Cellular Biochemistry, 2013, v. 114, n. 5, p. 1058, doi. 10.1002/jcb.24445
- By:
- Publication type:
- Article
HSP75 protects against cardiac hypertrophy and fibrosis.
- Published in:
- Journal of Cellular Biochemistry, 2011, v. 112, n. 7, p. 1787, doi. 10.1002/jcb.23091
- By:
- Publication type:
- Article
Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling.
- Published in:
- Journal of Cellular Biochemistry, 2010, v. 110, n. 5, p. 1111, doi. 10.1002/jcb.22623
- By:
- Publication type:
- Article
Breviscapine protects against cardiac hypertrophy through blocking PKC-α-dependent signaling.
- Published in:
- Journal of Cellular Biochemistry, 2010, v. 109, n. 6, p. 1158, doi. 10.1002/jcb.22495
- By:
- Publication type:
- Article
Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Evodiamine attenuates TGF-β1-induced fibroblast activation and endothelial to mesenchymal transition.
- Published in:
- Molecular & Cellular Biochemistry, 2017, v. 430, n. 1/2, p. 81, doi. 10.1007/s11010-017-2956-6
- By:
- Publication type:
- Article
Nobiletin attenuates cardiac dysfunction, oxidative stress, and inflammatory in streptozotocin: induced diabetic cardiomyopathy.
- Published in:
- Molecular & Cellular Biochemistry, 2016, v. 417, n. 1/2, p. 87, doi. 10.1007/s11010-016-2716-z
- By:
- Publication type:
- Article
Oleanolic acid alleviated pressure overload-induced cardiac remodeling.
- Published in:
- Molecular & Cellular Biochemistry, 2015, v. 409, n. 1/2, p. 145, doi. 10.1007/s11010-015-2520-1
- By:
- Publication type:
- Article
3,3'-Diindolylmethane Protects against Cardiac Hypertrophy via 5'-Adenosine Monophosphate- Activated Protein Kinase-α2.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0053427
- By:
- Publication type:
- Article
IKKi Deficiency Promotes Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0053412
- By:
- Publication type:
- Article
Activating Transcription Factor 3 Deficiency Promotes Cardiac Hypertrophy, Dysfunction, and Fibrosis Induced by Pressure Overload.
- Published in:
- PLoS ONE, 2011, v. 6, n. 10, p. 1, doi. 10.1371/journal.pone.0026744
- By:
- Publication type:
- Article
Paeoniflorin attenuates pressure overload-induced cardiac remodeling via inhibition of TGFβ/Smads and NF-κB pathways.
- Published in:
- Journal of Molecular Histology, 2013, v. 44, n. 3, p. 357, doi. 10.1007/s10735-013-9491-x
- By:
- Publication type:
- Article
T-bet deficiency attenuates cardiac remodelling in rats.
- Published in:
- Basic Research in Cardiology, 2018, v. 113, n. 3, p. 1, doi. 10.1007/s00395-018-0678-x
- By:
- Publication type:
- Article
Interferon regulatory factor 3 is a negative regulator of pathological cardiac hypertrophy.
- Published in:
- Basic Research in Cardiology, 2013, v. 108, n. 2, p. 1, doi. 10.1007/s00395-012-0326-9
- By:
- Publication type:
- Article
Liquiritin Attenuates Lipopolysaccharides-Induced Cardiomyocyte Injury via an AMP-Activated Protein Kinase-Dependent Signaling Pathway.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.648688
- By:
- Publication type:
- Article
Piperine Alleviates Doxorubicin-Induced Cardiotoxicity via Activating PPAR-γ in Mice.
- Published in:
- PPAR Research, 2019, p. 1, doi. 10.1155/2019/2601408
- By:
- Publication type:
- Article
Dickkopf-3 attenuates pressure overload-induced cardiac remodelling.
- Published in:
- Cardiovascular Research, 2014, v. 102, n. 1, p. 35, doi. 10.1093/cvr/cvu004
- By:
- Publication type:
- Article
Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3β and TGF-β1–Smad signalling.
- Published in:
- Cardiovascular Research, 2011, v. 92, n. 1, p. 85, doi. 10.1093/cvr/cvr159
- By:
- Publication type:
- Article
Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway.
- Published in:
- 2010
- By:
- Publication type:
- Correction notice
Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway.
- Published in:
- Journal of Cellular & Molecular Medicine, 2009, v. 13, n. 5, p. 909, doi. 10.1111/j.1582-4934.2008.00620.x
- By:
- Publication type:
- Article
Grape seed proanthocyanidins attenuate vascular smooth muscle cell proliferation via blocking phosphatidylinositol 3-kinase-dependent signaling pathways.
- Published in:
- Journal of Cellular Physiology, 2010, v. 223, n. 3, p. 713, doi. 10.1002/jcp.22080
- By:
- Publication type:
- Article
Leukocyte immunoglobulin-like receptor B4 protects against cardiac hypertrophy via SHP-2-dependent inhibition of the NF-κB pathway.
- Published in:
- Journal of Molecular Medicine, 2020, v. 98, n. 5, p. 691, doi. 10.1007/s00109-020-01896-w
- By:
- Publication type:
- Article
Erratum to: Disruption of mindin exacerbates cardiac hypertrophy and fibrosis.
- Published in:
- 2017
- By:
- Publication type:
- Erratum
Disruption of mindin exacerbates cardiac hypertrophy and fibrosis.
- Published in:
- Journal of Molecular Medicine, 2012, v. 90, n. 8, p. 895, doi. 10.1007/s00109-012-0883-2
- By:
- Publication type:
- Article
Resveratrol Inhibits Ischemia-Induced Myocardial Senescence Signals and NLRP3 Inflammasome Activation.
- Published in:
- Oxidative Medicine & Cellular Longevity, 2020, p. 1, doi. 10.1155/2020/2647807
- By:
- Publication type:
- Article
OX40 regulates pressure overload-induced cardiac hypertrophy and remodelling via CD4<sup>+</sup> T-cells.
- Published in:
- Clinical Science, 2016, v. 130, n. 22, p. 2061, doi. 10.1042/CS20160074
- By:
- Publication type:
- Article
Puerarin attenuates the inflammatory response and apoptosis in LPS-stimulated cardiomyocytes.
- Published in:
- Experimental & Therapeutic Medicine, 2016, v. 11, n. 2, p. 415, doi. 10.3892/etm.2015.2910
- By:
- Publication type:
- Article
Icariin attenuates angiotensin II-induced hypertrophy and apoptosis in H9c2 cardiomyocytes by inhibiting reactive oxygen species-dependent JNK and p38 pathways.
- Published in:
- Experimental & Therapeutic Medicine, 2014, v. 7, n. 5, p. 1116, doi. 10.3892/etm.2014.1598
- By:
- Publication type:
- Article
Shensongyangxin protects against pressure overload-induced cardiac hypertrophy.
- Published in:
- Molecular Medicine Reports, 2016, v. 13, n. 1, p. 980, doi. 10.3892/mmr.2015.4598
- By:
- Publication type:
- Article
Sanguinarine inhibits angiotensin II-induced apoptosis in H9c2 cardiac cells via restoring reactive oxygen species-mediated decreases in the mitochondrial membrane potential.
- Published in:
- Molecular Medicine Reports, 2015, v. 12, n. 3, p. 3400, doi. 10.3892/mmr.2015.3841
- By:
- Publication type:
- Article
3,3'-Diindolylmethane attenuates cardiac H9c2 cell hypertrophy through 5'-adenosine monophosphate-activated protein kinase-α.
- Published in:
- Molecular Medicine Reports, 2015, v. 12, n. 1, p. 1247, doi. 10.3892/mmr.2015.3523
- By:
- Publication type:
- Article
Icariin protects H9c2 cardiomyocytes from lipopolysaccharide-induced injury via inhibition of the reactive oxygen species-dependent c-un N-terminal kinases/nuclear factor-κB pathway.
- Published in:
- Molecular Medicine Reports, 2015, v. 11, n. 6, p. 4327, doi. 10.3892/mmr.2015.3289
- By:
- Publication type:
- Article